Arecoline

Arecoline at a Glance

Arecoline is the principal alkaloid of the areca nut, the seed of the areca palm (Areca catechu), and it is a partial agonist at both muscarinic and nicotinic acetylcholine receptors ^{1,2Reference 1Liu YJ et al. · 2016ReviewThe pharmacology, toxicology and potential applications of arecoline: a review — reviewView study →Reference 2Volgin AD et al. · 2019ReviewDARK Classics in Chemical Neuroscience: Arecoline — reviewView study →}. That single pharmacology explains almost everything the nut does: the flush of saliva, the gut stimulation, the paralysis of tapeworms, the alertness and mild euphoria that make it the world’s fourth most-used psychoactive substance after alcohol, nicotine and caffeine ^{2Reference 2Volgin AD et al. · 2019ReviewDARK Classics in Chemical Neuroscience: Arecoline — reviewView study →}.

It is also the reason the nut is dangerous. The same molecule is genotoxic, nitrosates in the mouth to reactive nitrosamines, and drives fibroblasts to lay down collagen faster than the tissue can break it down — the pathway to oral submucous fibrosis and, from there, to oral cancer ^{9,10,11Reference 9Zhang P et al. · 2022ReviewMolecular mechanisms of malignant transformation of oral submucous fibrosis by different betel quid constituents — does fibroblast senescence play a role? — reviewView study →Reference 10Oliveira NG et al. · 2021ReviewGenetic toxicology and toxicokinetics of arecoline and related areca nut compounds: an updated reviewView study →Reference 11Mishra G · 2010ObservationalMatrix metalloproteinase-1 expression in oral submucous fibrosis: an immunohistochemical study — case-control tissue studyView study →}. The areca nut is an IARC Group 1 human carcinogen; arecoline itself was evaluated in 2021 and placed in Group 2B — possibly carcinogenic to humans — on strong mechanistic evidence ^{3Reference 3International Agency for Research on Can · 2021ReviewArecoline, in: Acrolein, Crotonaldehyde, and Arecoline — IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Volume 128. https://www.ncbi.nlm.nih.gov/books/NBK589584/View study →}.

Arecoline is unusual in that its therapeutic and its carcinogenic literature are not two separate stories about the same plant. They are the same receptor agonism, read at two different timescales.

Two Uses, One Mechanism

Most dual-use molecules are dual-use because the dose changes: a therapeutic window at one exposure, toxicity above it. Arecoline is not that. Its cholinergic agonism is what makes it a de-worming agent, what made it a plausible Alzheimer’s candidate, and what makes it self-reinforcing enough to be chewed daily for decades — and it is that daily chewing, not any single dose, that produces the disease.

The practical consequence is that the harm cannot be dosed away. A cestode is paralysed by a single purgative dose given once. A memory effect was obtained by continuous intravenous infusion under monitoring. Oral submucous fibrosis is produced by repeated mucosal contact over years, at concentrations far below anything acutely toxic, and it is irreversible. Three different exposure patterns, one molecule, and no version of habitual oral use that captures the first two without the third.

Established Uses

The one place arecoline is still genuinely used is parasitology, and mostly not in people.

In veterinary medicine arecoline — almost always as the hydrobromide salt — has been used as an anthelmintic against cestodes (tapeworms), as a cathartic and as a cholinergic agent ^{3Reference 3International Agency for Research on Can · 2021ReviewArecoline, in: Acrolein, Crotonaldehyde, and Arecoline — IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Volume 128. https://www.ncbi.nlm.nih.gov/books/NBK589584/View study →}. The mechanism is straightforward: cholinergic overstimulation paralyses the worm’s musculature so it loses its grip on the gut wall, and the drug’s own purgative action expels it. An oral course of 40 mg of arecoline hydrobromide daily for five days gave complete control of tapeworm in dogs, with much weaker activity against ascarid roundworms ^{3Reference 3International Agency for Research on Can · 2021ReviewArecoline, in: Acrolein, Crotonaldehyde, and Arecoline — IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Volume 128. https://www.ncbi.nlm.nih.gov/books/NBK589584/View study →}.

That role survives today in a narrower form. Arecoline purgation remains a field diagnostic for Echinococcus granulosus in dogs — dosing a dog and examining what is expelled is still used to establish infection prevalence in echinococcosis-control programmes, precisely because it recovers whole worms an owner can see ^{22Reference 22Dakkak A et al. · 2017ObservationalEchinococcus granulosus infection in dogs in Sidi Kacem Province (North-West Morocco) — cross-sectional surveyView study →}.

On the human side, the crude drug rather than the isolate carries the listing: the dried seed (Semen Arecae, bīng láng) is a pharmacopoeial anthelmintic in Chinese medicine, with arecoline as its quality marker, and the alkaloid was named in several national pharmacopoeias before being displaced by better-tolerated drugs ^{3Reference 3International Agency for Research on Can · 2021ReviewArecoline, in: Acrolein, Crotonaldehyde, and Arecoline — IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Volume 128. https://www.ncbi.nlm.nih.gov/books/NBK589584/View study →}. Direct administration of arecoline to people is now rare to nonexistent ^{3Reference 3International Agency for Research on Can · 2021ReviewArecoline, in: Acrolein, Crotonaldehyde, and Arecoline — IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Volume 128. https://www.ncbi.nlm.nih.gov/books/NBK589584/View study →}.

The Abandoned Alzheimer’s Programme

Arecoline is one of the few plant alkaloids with a replicated human cognitive signal, and it is worth being precise about what that signal was.

Before the cholinesterase inhibitors existed, the cholinergic hypothesis of Alzheimer’s disease made a centrally-active muscarinic agonist an obvious thing to try. Two US infusion studies did exactly that. In a double-blind, placebo-controlled study, continuous low-dose intravenous arecoline improved verbal memory in five of nine patients with mild-to-moderate Alzheimer’s disease, following an inverted-U dose–response — better at an intermediate dose than at higher or lower ones — and without adverse effects at each patient’s optimised dose ^{4Reference 4Soncrant TT et al. · 1993RCTMemory improvement without toxicity during chronic, low dose intravenous arecoline in Alzheimer’s disease — randomised placebo-controlled trialView study →}. A companion long-term infusion study reported the same partial improvement on selective-reminding tasks ^{5Reference 5Raffaele KC et al. · 1991Clinical trialEffects of long-term continuous infusion of the muscarinic cholinergic agonist arecoline on verbal memory in dementia of the Alzheimer type — clinical trialView study →}.

Three things about it matter more than the result:

The route was intravenous and continuous. Arecoline’s plasma half-life in those patients was measured in minutes, in two phases — under a minute, then about nine ^{3Reference 3International Agency for Research on Can · 2021ReviewArecoline, in: Acrolein, Crotonaldehyde, and Arecoline — IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Volume 128. https://www.ncbi.nlm.nih.gov/books/NBK589584/View study →}. Nothing swallowed or chewed reproduces that exposure.
The dose was individually titrated. The inverted-U response means there was no single effective dose; too much was as useless as too little ^{4Reference 4Soncrant TT et al. · 1993RCTMemory improvement without toxicity during chronic, low dose intravenous arecoline in Alzheimer’s disease — randomised placebo-controlled trialView study →}.
The programme was not carried forward. Donepezil and its relatives arrived, and a short-half-life agonist requiring an infusion pump had nothing to offer against a once-daily tablet.

It is a real, human, replicated finding about the isolated molecule. It is not evidence for the nut, and it never became a drug.

What It's Used For

Everything below rests on the same receptor action. The evidence divides sharply by route and by preparation: the cestode and cognition work is on the isolated alkaloid, the psychoactive and dependence work is on human chewing, and the antioxidant, analgesic and neuroprotective signals are cell and rodent studies of arecoline given in ways no chewer experiences.

A genuine anthelmintic, mostly veterinary:cholinergic paralysis of cestode musculature underwrites established de-worming use in dogs and the pharmacopoeial listing of the crude seed; arecoline purgation is still a field diagnostic for Echinococcus ^{3,22Reference 3International Agency for Research on Can · 2021ReviewArecoline, in: Acrolein, Crotonaldehyde, and Arecoline — IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Volume 128. https://www.ncbi.nlm.nih.gov/books/NBK589584/View study →Reference 22Dakkak A et al. · 2017ObservationalEchinococcus granulosus infection in dogs in Sidi Kacem Province (North-West Morocco) — cross-sectional surveyView study →}.

A replicated but abandoned cognitive signal:continuous intravenous low-dose arecoline improved verbal memory in Alzheimer’s patients across two 1990s studies, on an inverted-U dose–response — a route and exposure no oral or chewed preparation can deliver ^{4,5Reference 4Soncrant TT et al. · 1993RCTMemory improvement without toxicity during chronic, low dose intravenous arecoline in Alzheimer’s disease — randomised placebo-controlled trialView study →Reference 5Raffaele KC et al. · 1991Clinical trialEffects of long-term continuous infusion of the muscarinic cholinergic agonist arecoline on verbal memory in dementia of the Alzheimer type — clinical trialView study →}.

A dependence-forming psychostimulant:arecoline excites ventral tegmental area dopaminergic neurons and raises burst firing in rats, the circuitry that produces both the alertness people chew for and the withdrawal syndrome on stopping ^{2,6Reference 2Volgin AD et al. · 2019ReviewDARK Classics in Chemical Neuroscience: Arecoline — reviewView study →Reference 6Lan Q et al. · 2022AnimalArecoline induces an excitatory response in ventral tegmental area dopaminergic neurons in anesthetized rats — animal modelView study →}.

The headline that governs the rest:the same molecule is genotoxic, nitrosates to reactive nitrosamines in the mouth, and drives collagen accumulation while suppressing its breakdown — the mechanism of oral submucous fibrosis and malignant transformation ^{9,10,11Reference 9Zhang P et al. · 2022ReviewMolecular mechanisms of malignant transformation of oral submucous fibrosis by different betel quid constituents — does fibroblast senescence play a role? — reviewView study →Reference 10Oliveira NG et al. · 2021ReviewGenetic toxicology and toxicokinetics of arecoline and related areca nut compounds: an updated reviewView study →Reference 11Mishra G · 2010ObservationalMatrix metalloproteinase-1 expression in oral submucous fibrosis: an immunohistochemical study — case-control tissue studyView study →}. No benefit above is delivered by chewing.

Evidence by IndicationStrength of support · Beta

The reason hundreds of millions of people chew. Arecoline’s partial agonism at nicotinic and muscarinic receptors produces alertness, warmth, mild elation and anxiolysis, and it is described as the world’s fourth most commonly used psychoactive substance after alcohol, nicotine and caffeine ^{2Reference 2Volgin AD et al. · 2019ReviewDARK Classics in Chemical Neuroscience: Arecoline — reviewView study →}.

In anaesthetised rats, arecoline significantly raises the firing rate of ventral tegmental area dopaminergic neurons — but not neighbouring GABAergic neurons — and increases burst rate, burst duration and spikes per burst, the electrophysiological signature of a reinforcing drug ^{6Reference 6Lan Q et al. · 2022AnimalArecoline induces an excitatory response in ventral tegmental area dopaminergic neurons in anesthetized rats — animal modelView study →}.

Part of the neurotransmitter shift appears to be routed through the gut: arecoline alters intestinal microbiota, digestive-enzyme activity and downstream neurotransmitter levels in mice ^{19Reference 19Di W et al. · 2025AnimalArecoline triggers psychostimulant responses by modulating the intestinal microbiota to influence neurotransmitter levels and digestive enzyme activity — animal modelView study →}.

Dependence follows the same pharmacology. Tolerance, dependence and a withdrawal syndrome of lethargy, anxiety, irritability and insomnia are documented on cessation ^{2Reference 2Volgin AD et al. · 2019ReviewDARK Classics in Chemical Neuroscience: Arecoline — reviewView study →}. Rates depend heavily on the criteria and population sampled; a Taiwanese survey applying DSM-IV and ICD-10 criteria found a six-month dependency rate of 42.9–45.6% among betel-quid chewers ^{7Reference 7Yen HY et al. · 2018ObservationalBetel quid chewing, personality and mood: betel quid chewing associated with low extraversion and negative mood — cross-sectional surveyView study →}.

Gap: this is the one application with abundant human data, and none of it is therapeutic — it documents an exposure, not a treatment. A four-alkaloid zebrafish comparison with molecular docking found all four primary areca alkaloids psychoactive, so the whole-nut effect is not attributable to arecoline alone ^{16Reference 16Siregar P et al. · 2022AnimalComparison of the psychoactive activity of four primary areca nut alkaloids in zebrafish by behavioral approach and molecular docking — animal modelView study →}.

Continuous low-dose intravenous arecoline improved verbal memory in five of nine patients with mild-to-moderate Alzheimer’s disease in a double-blind, placebo-controlled study, following an inverted-U dose–response and producing no adverse effects at each patient’s optimised dose ^{4Reference 4Soncrant TT et al. · 1993RCTMemory improvement without toxicity during chronic, low dose intravenous arecoline in Alzheimer’s disease — randomised placebo-controlled trialView study →}.

A companion long-term infusion study found the same partial improvement on selective-reminding tasks ^{5Reference 5Raffaele KC et al. · 1991Clinical trialEffects of long-term continuous infusion of the muscarinic cholinergic agonist arecoline on verbal memory in dementia of the Alzheimer type — clinical trialView study →}.

This is a genuine replicated human signal for a centrally-active muscarinic agonist, obtained before the cholinesterase inhibitors existed.

Gap: the route is disqualifying for herbal purposes. Plasma half-lives in those patients ran to under a minute and then about nine minutes in a two-phase decline ^{3Reference 3International Agency for Research on Can · 2021ReviewArecoline, in: Acrolein, Crotonaldehyde, and Arecoline — IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Volume 128. https://www.ncbi.nlm.nih.gov/books/NBK589584/View study →}, so the effect depended entirely on continuous infusion of the purified alkaloid at an individually titrated dose. No chewed, decocted or swallowed preparation can reproduce it, and the drug programme was not continued ^{4,5Reference 4Soncrant TT et al. · 1993RCTMemory improvement without toxicity during chronic, low dose intravenous arecoline in Alzheimer’s disease — randomised placebo-controlled trialView study →Reference 5Raffaele KC et al. · 1991Clinical trialEffects of long-term continuous infusion of the muscarinic cholinergic agonist arecoline on verbal memory in dementia of the Alzheimer type — clinical trialView study →}.

Mechanisms

Target / pathway	Effect	Relevant to
Muscarinic ACh receptors (partial agonism)	salivation, gut motility, cortical cholinergic tone, cestode neuromuscular paralysis	anthelmintic · memory · sialagogue
Nicotinic ACh receptors (partial agonism)	CNS stimulation, autonomic activation	psychoactivity · dependence
Ventral tegmental area dopaminergic neurons	increased firing rate and burst firing (GABAergic neurons unaffected)	reinforcement · dependence
Nrf2 ↑ / HO-1 ↑ / Keap1 ↓	antioxidant-enzyme induction in stressed neuronal cells	in-vitro neuroprotection
NF-κB signalling ↓	reduced pro-inflammatory cytokine release	preclinical anti-inflammatory
Anterior cingulate cortex synaptic transmission ↓	raised nociceptive threshold in mice	preclinical analgesia
Nitrosation to N-nitrosoguvacoline / N-nitrosoguvacine	reactive, DNA-damaging nitrosamines formed in the chewer’s saliva	carcinogenesis
TGF-β1 signalling ↑ in oral fibroblasts	collagen synthesis up ~150%	oral submucous fibrosis
Matrix metalloproteinase-1 (collagenase-1) ↓	collagen breakdown suppressed	oral submucous fibrosis
Oxidation to arecoline N-oxide	a metabolite more fibrogenic and more genotoxic than the parent	fibrosis · genotoxicity

The two halves of this table are one mechanism seen twice. Cholinergic agonism is the therapeutic column; the electrophilic, nitrosatable ester that carries that agonism is the carcinogenic one.

Pharmacokinetics

Arecoline is small, lipophilic and absorbed rapidly by every route tested — buccal, oral, intranasal, intramuscular and intravenous ^{3Reference 3International Agency for Research on Can · 2021ReviewArecoline, in: Acrolein, Crotonaldehyde, and Arecoline — IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Volume 128. https://www.ncbi.nlm.nih.gov/books/NBK589584/View study →}. It is also cleared very fast. In fifteen Alzheimer’s patients given 5 mg intravenously over 30 minutes, plasma concentrations fell biexponentially with half-lives of about 0.95 minutes and 9.3 minutes ^{3Reference 3International Agency for Research on Can · 2021ReviewArecoline, in: Acrolein, Crotonaldehyde, and Arecoline — IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Volume 128. https://www.ncbi.nlm.nih.gov/books/NBK589584/View study →}; in dogs given 3 mg/kg orally as the hydrobromide, plasma peaked at 60.6 ng/mL after two hours with absorption and elimination half-lives of 50 and 69 minutes ^{3Reference 3International Agency for Research on Can · 2021ReviewArecoline, in: Acrolein, Crotonaldehyde, and Arecoline — IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Volume 128. https://www.ncbi.nlm.nih.gov/books/NBK589584/View study →}.

The metabolism is where the toxicology lives. Arecoline is hydrolysed to arecaidine and oxidised to arecoline N-oxide, and in areca chewers arecaidine — not arecoline — is the dominant urinary species: mean urinary concentrations in regular chewers run to 5,816 ng/mg creatinine for arecaidine against 23.9 for arecoline, with elimination half-lives of 4.3 hours and 0.97 hours respectively ^{3Reference 3International Agency for Research on Can · 2021ReviewArecoline, in: Acrolein, Crotonaldehyde, and Arecoline — IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Volume 128. https://www.ncbi.nlm.nih.gov/books/NBK589584/View study →}. Arecoline N-oxide is more than a disposal route: it induces the fibrotic gene programme more strongly than arecoline itself and raises the DNA-damage marker γ-H2A.X both in cultured oral fibroblasts and in mice ^{12Reference 12Kuo TM et al. · 2015In vitroFibrotic effects of arecoline N-oxide in oral potentially malignant disorders — in vitro and animal modelView study →}.

Arecoline crosses into milk and to the fetus. It has been measured at 18–159.9 µg/L in the breast milk of betel-quid chewers, and in the meconium and urine of infants born to mothers who used areca nut in pregnancy ^{3Reference 3International Agency for Research on Can · 2021ReviewArecoline, in: Acrolein, Crotonaldehyde, and Arecoline — IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Volume 128. https://www.ncbi.nlm.nih.gov/books/NBK589584/View study →}.

Clinical Trials

There is no active clinical programme. The human interventional record is the pair of 1990s intravenous infusion studies in Alzheimer’s disease; everything since is observational epidemiology of chewing, or preclinical.

Completed	Planned	Terminated	Preclinical
Two small IV infusion studies in Alzheimer’s disease (1991, 1993)	—	Cholinergic-agonist programme discontinued after the cholinesterase inhibitors	Anthelmintic mechanism; VTA electrophysiology; Nrf2/HO-1; ACC analgesia; fibrosis and genotoxicity

Last checked: September 2026.

Isolate vs. Plant Studies

The split here is unusually clean, and it runs in the opposite direction to most plant compounds.

Every therapeutic result belongs to the isolate. The Alzheimer’s memory data used purified arecoline delivered intravenously by continuous infusion ^{4,5Reference 4Soncrant TT et al. · 1993RCTMemory improvement without toxicity during chronic, low dose intravenous arecoline in Alzheimer’s disease — randomised placebo-controlled trialView study →Reference 5Raffaele KC et al. · 1991Clinical trialEffects of long-term continuous infusion of the muscarinic cholinergic agonist arecoline on verbal memory in dementia of the Alzheimer type — clinical trialView study →}. The anthelmintic record is arecoline hydrobromide, an isolated salt, given orally to dogs ^{3,22Reference 3International Agency for Research on Can · 2021ReviewArecoline, in: Acrolein, Crotonaldehyde, and Arecoline — IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Volume 128. https://www.ncbi.nlm.nih.gov/books/NBK589584/View study →Reference 22Dakkak A et al. · 2017ObservationalEchinococcus granulosus infection in dogs in Sidi Kacem Province (North-West Morocco) — cross-sectional surveyView study →}. The antioxidant, analgesic and neuroprotective signals are the pure compound applied to cell lines or injected into rodents ^{17,18Reference 17Zhang X et al. · 2025In vitroNeuroprotective effects and mechanisms of arecoline against H2O2-induced damage in SH-SY5Y cells — in vitroView study →Reference 18Chen QY et al. · 2024AnimalInhibition of cortical synaptic transmission, behavioral nociceptive, and anxiodepressive-like responses by arecoline in adult miceView study →}.

Every human outcome belongs to the plant. Oral submucous fibrosis, oral squamous cell carcinoma, dependence, metabolic syndrome and the reproductive findings all come from people chewing areca nut — a mixture in which arecoline is one of four alkaloids alongside arecaidine, guvacine and guvacoline, plus condensed tannins and slaked lime ^{8,9,16Reference 8Warnakulasuriya S · 2022Systematic reviewAreca nut and oral cancer: evidence from studies conducted in humans — systematic reviewView study →Reference 9Zhang P et al. · 2022ReviewMolecular mechanisms of malignant transformation of oral submucous fibrosis by different betel quid constituents — does fibroblast senescence play a role? — reviewView study →Reference 16Siregar P et al. · 2022AnimalComparison of the psychoactive activity of four primary areca nut alkaloids in zebrafish by behavioral approach and molecular docking — animal modelView study →}.

That has a specific consequence: the benefits do not transfer to the exposure, and the harms cannot be attributed to arecoline alone. A zebrafish study comparing all four primary areca alkaloids head-to-head with molecular docking found psychoactivity across the set, not confined to arecoline ^{16Reference 16Siregar P et al. · 2022AnimalComparison of the psychoactive activity of four primary areca nut alkaloids in zebrafish by behavioral approach and molecular docking — animal modelView study →}, and the nitrosamines found in chewers’ saliva may derive from guvacoline and guvacine as much as from arecoline ^{3Reference 3International Agency for Research on Can · 2021ReviewArecoline, in: Acrolein, Crotonaldehyde, and Arecoline — IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Volume 128. https://www.ncbi.nlm.nih.gov/books/NBK589584/View study →}. The slaked lime in the quid is not filler either — it raises oral pH and frees the alkaloids for mucosal absorption, so the traditional preparation is a delivery system, not a dilution.

Prevalence in Nature

Arecoline is essentially a one-genus molecule. It occurs naturally in the areca nut — the seed of the fruit of the areca palm, Areca catechu (Arecaceae) — cultivated across South and South-East Asia, the Pacific and parts of East Africa ^{3Reference 3International Agency for Research on Can · 2021ReviewArecoline, in: Acrolein, Crotonaldehyde, and Arecoline — IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Volume 128. https://www.ncbi.nlm.nih.gov/books/NBK589584/View study →}. It is the marker alkaloid of that seed, accompanied by three structurally related pyridine alkaloids: arecaidine (its hydrolysis product), guvacine and guvacoline.

Reported concentrations vary widely with cultivar, ripeness, processing and analytical method, and the older gravimetric figures run higher than modern mass spectrometry. In Chinese pharmacopoeial preparations of Arecae semen, average arecoline ran 3.38 mg/g in the raw seed, 2.23 mg/g after stir-frying and 1.36 mg/g in the carbonised form — processing measurably lowers it ^{3Reference 3International Agency for Research on Can · 2021ReviewArecoline, in: Acrolein, Crotonaldehyde, and Arecoline — IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Volume 128. https://www.ncbi.nlm.nih.gov/books/NBK589584/View study →}. An LC-MS/MS survey of commercial areca-nut products from India, China and the United States found arecoline at 0.64–2.22 mg/g, and notably found guvacine to be the most abundant alkaloid of the four at 1.39–8.16 mg/g ^{21Reference 21Jain V et al. · 2017Analysis of alkaloids in areca nut-containing products by liquid chromatography-tandem mass spectrometryView study →}. Pan masala samples from Kolkata carried 130–415 µg per gram of dried product ^{3Reference 3International Agency for Research on Can · 2021ReviewArecoline, in: Acrolein, Crotonaldehyde, and Arecoline — IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Volume 128. https://www.ncbi.nlm.nih.gov/books/NBK589584/View study →}.

The molecule is not quite confined to A. catechu. Areca triandra from Hainan carries arecoline at 0.06–0.77 mg/g across unripe and ripe fruits, spadices, flowers and leaves — lower than the cultivated species, and distributed through the whole plant rather than concentrated in the seed ^{3Reference 3International Agency for Research on Can · 2021ReviewArecoline, in: Acrolein, Crotonaldehyde, and Arecoline — IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Volume 128. https://www.ncbi.nlm.nih.gov/books/NBK589584/View study →}.

Discovery & Synthesis

Arecoline was first isolated from areca nuts by the German pharmacist Ernst Jahns in 1888, in the paper that established the areca alkaloid group ^{3Reference 3International Agency for Research on Can · 2021ReviewArecoline, in: Acrolein, Crotonaldehyde, and Arecoline — IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Volume 128. https://www.ncbi.nlm.nih.gov/books/NBK589584/View study →}. A 1911 edition of the German Pharmacopoeia describes production of the hydrobromide by extracting the nuts with acidified water followed by clean-up steps; the first industrial-scale extraction, using diethyl ether, was reported in 1927 ^{3Reference 3International Agency for Research on Can · 2021ReviewArecoline, in: Acrolein, Crotonaldehyde, and Arecoline — IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Volume 128. https://www.ncbi.nlm.nih.gov/books/NBK589584/View study →}. The name follows the genus — Areca plus the alkaloid suffix — and the compound was for a time sold under the trade name taeniolin, after the tapeworms it was given to expel.

Structurally it is the methyl ester of arecaidine (N-methyl-1,2,5,6-tetrahydronicotinic acid), which is why hydrolysis of that ester is its main metabolic fate. Several synthetic routes exist — from nicotinic acid and iodomethane, from methylamine with formaldehyde and acetaldehyde, or from ethyl acrylate and methylamine — with the most modern approach starting from nicotinic acid methyl ester and methyl iodide ^{3Reference 3International Agency for Research on Can · 2021ReviewArecoline, in: Acrolein, Crotonaldehyde, and Arecoline — IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Volume 128. https://www.ncbi.nlm.nih.gov/books/NBK589584/View study →}. Which route dominates industrially is not documented.

Manufacture today is entirely for research and veterinary supply, not for medicine. Arecoline is traded mainly as the hydrobromide and secondarily as the hydrochloride or free base, at purities above 99% for the hydrobromide; international chemical directories list a few dozen suppliers worldwide ^{3Reference 3International Agency for Research on Can · 2021ReviewArecoline, in: Acrolein, Crotonaldehyde, and Arecoline — IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Volume 128. https://www.ncbi.nlm.nih.gov/books/NBK589584/View study →}. There is no pharmaceutical production of arecoline for human use.

Patents: not yet researched.

Toxicity & Safety

Arecoline carries toxic and carcinogen flags, and the second is the load-bearing one. The areca nut has been classified by IARC as carcinogenic to humans (Group 1) since 2004; arecoline itself was evaluated separately in 2021 and placed in Group 2B, possibly carcinogenic to humans, on the basis of strong mechanistic evidence — it is electrophilic, it is genotoxic, it induces oxidative stress, and it alters DNA repair and causes genomic instability in experimental systems — together with limited evidence of carcinogenicity in animals ^{3Reference 3International Agency for Research on Can · 2021ReviewArecoline, in: Acrolein, Crotonaldehyde, and Arecoline — IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Volume 128. https://www.ncbi.nlm.nih.gov/books/NBK589584/View study →}.

Safety at a Glance

ToxicCarcinogenDependence risk

Group 2B carcinogen in a Group 1 carcinogenic exposure. Habitual areca chewing causes oral submucous fibrosis and oral squamous cell carcinoma; there is no safe level of use.
Dependence-forming. Tolerance, dependence and a withdrawal syndrome of lethargy, anxiety, irritability and insomnia; measured six-month dependency rates of 42.9–45.6% in chewers.
Reaches the fetus and breast milk. Measured in milk at 18–159.9 µg/L in chewers, and in infant meconium and urine after maternal use; seed extract was antiovulatory and abortifacient in rats.
Cholinergic toxicity in overdose. Salivation, sweating, bradycardia, bronchospasm, vomiting and diarrhoea — the classic muscarinic syndrome, with a narrow margin between the anthelmintic dose and it.
Chewing worsens metabolic risk rather than improving it. Preclinical reports of glucose- and lipid-lowering are contradicted by the human cohorts, which find metabolic syndrome, obesity, hyperglycaemia and type 2 diabetes.

Full Safety & Interactions Detail

Oral submucous fibrosis — the defining harm. OSMF is a chronic, progressive, irreversible fibrosis of the oral mucosa that stiffens the tissue, restricts mouth opening, and carries a substantial risk of malignant transformation to oral squamous cell carcinoma ^{8,9Reference 8Warnakulasuriya S · 2022Systematic reviewAreca nut and oral cancer: evidence from studies conducted in humans — systematic reviewView study →Reference 9Zhang P et al. · 2022ReviewMolecular mechanisms of malignant transformation of oral submucous fibrosis by different betel quid constituents — does fibroblast senescence play a role? — reviewView study →}. Arecoline drives it from both ends of collagen turnover at once: it stimulates oral fibroblasts to increase collagen production by around 150%, while matrix metalloproteinase-1 — collagenase-1, the enzyme that clears collagen — is significantly under-expressed in the epithelium and connective tissue of OSMF tissue compared with normal buccal mucosa ^{11Reference 11Mishra G · 2010ObservationalMatrix metalloproteinase-1 expression in oral submucous fibrosis: an immunohistochemical study — case-control tissue studyView study →}. Synthesis up, breakdown down, for years. Its metabolite arecoline N-oxide is worse than the parent, raising TGF-β1, S100A4, MMP-9, IL-6 and fibronectin more strongly than arecoline while lowering E-cadherin, and increasing the DNA-damage marker γ-H2A.X in fibroblasts and in mice ^{12Reference 12Kuo TM et al. · 2015In vitroFibrotic effects of arecoline N-oxide in oral potentially malignant disorders — in vitro and animal modelView study →}. Fibroblast senescence induced by quid constituents has been proposed as the link from fibrosis to tumour progression ^{9Reference 9Zhang P et al. · 2022ReviewMolecular mechanisms of malignant transformation of oral submucous fibrosis by different betel quid constituents — does fibroblast senescence play a role? — reviewView study →}.

Genotoxicity and nitrosation. Arecoline is electrophilic and genotoxic in human primary cells ^{3,10Reference 3International Agency for Research on Can · 2021ReviewArecoline, in: Acrolein, Crotonaldehyde, and Arecoline — IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Volume 128. https://www.ncbi.nlm.nih.gov/books/NBK589584/View study →Reference 10Oliveira NG et al. · 2021ReviewGenetic toxicology and toxicokinetics of arecoline and related areca nut compounds: an updated reviewView study →}. In the mouth it also nitrosates: N-nitrosoguvacoline and N-nitrosoguvacine have been detected in the saliva of betel-quid chewers, though these may form from guvacoline and guvacine as well as from arecoline ^{3Reference 3International Agency for Research on Can · 2021ReviewArecoline, in: Acrolein, Crotonaldehyde, and Arecoline — IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Volume 128. https://www.ncbi.nlm.nih.gov/books/NBK589584/View study →}. The relevant epidemiology is unambiguous — areca nut is causally associated with oral cancer in human studies, with or without tobacco in the quid ^{8Reference 8Warnakulasuriya S · 2022Systematic reviewAreca nut and oral cancer: evidence from studies conducted in humans — systematic reviewView study →}.

Dependence and withdrawal. Arecoline produces tolerance and dependence through VTA dopaminergic reinforcement ^{2,6Reference 2Volgin AD et al. · 2019ReviewDARK Classics in Chemical Neuroscience: Arecoline — reviewView study →Reference 6Lan Q et al. · 2022AnimalArecoline induces an excitatory response in ventral tegmental area dopaminergic neurons in anesthetized rats — animal modelView study →}. Applying DSM-IV and ICD-10 criteria, a Taiwanese survey found a six-month dependency rate of 42.9–45.6% among chewers ^{7Reference 7Yen HY et al. · 2018ObservationalBetel quid chewing, personality and mood: betel quid chewing associated with low extraversion and negative mood — cross-sectional surveyView study →}; reported rates elsewhere vary widely with criteria and population. Cessation brings lethargy, anxiety, irritability and insomnia ^{2Reference 2Volgin AD et al. · 2019ReviewDARK Classics in Chemical Neuroscience: Arecoline — reviewView study →}.

Acute cholinergic toxicity. As a muscarinic and nicotinic agonist, arecoline in excess produces the expected cholinergic syndrome — profuse salivation, sweating, lacrimation, bradycardia, bronchoconstriction, nausea, vomiting, diarrhoea and abdominal cramping. This is the reason its anthelmintic use was always dosed conservatively and the reason it was displaced by drugs with wider margins ^{3Reference 3International Agency for Research on Can · 2021ReviewArecoline, in: Acrolein, Crotonaldehyde, and Arecoline — IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Volume 128. https://www.ncbi.nlm.nih.gov/books/NBK589584/View study →}.

Systemic effects of chewing. Beyond the mouth, areca-nut use has been associated in human studies with cardiovascular and cerebrovascular disorders, hepatic disease, oesophageal inflammation and fibrosis, renal disorders and respiratory symptoms ^{15Reference 15Javed F et al. · 2010ReviewSystemic conditions associated with areca nut usage: a literature review — reviewView study →}. The metabolic direction is the opposite of what preclinical work suggested: a systematic review found areca-nut chewing a significant risk factor for metabolic syndrome ^{13Reference 13Javed F et al. · 2012Systematic reviewAreca-nut chewing habit is a significant risk factor for metabolic syndrome: a systematic reviewView study →}, and a cross-sectional study found the association harmful rather than protective ^{14Reference 14Shafique K et al. · 2013ObservationalAreca nut chewing and metabolic syndrome: evidence of a harmful relationship — cross-sectional studyView study →}. Reports of arecoline lowering cholesterol or glucose in animals should not be read as a human benefit.

Reproductive and developmental. Areca catechu seed extract was antiovulatory and abortifacient in female rats ^{20Reference 20Shrestha J et al. · 2010AnimalAntiovulatory and abortifacient effects of Areca catechu (betel nut) in female ratsView study →}. Arecoline reaches the human fetus and infant: it has been measured in breast milk at 18–159.9 µg/L in chewers, and in the meconium and urine of infants whose mothers used areca nut during pregnancy ^{3Reference 3International Agency for Research on Can · 2021ReviewArecoline, in: Acrolein, Crotonaldehyde, and Arecoline — IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Volume 128. https://www.ncbi.nlm.nih.gov/books/NBK589584/View study →}. Developmental and embryotoxic effects are documented in the review literature ^{23Reference 23Huang G et al. · 2024ReviewRecent advance on biological activity and toxicity of arecoline in edible areca (betel) nut: a review — reviewView study →}. Pregnancy and lactation decisions are made at the herb and product level, not at the molecule level — the finding is stated here as a cited risk.

Interactions. Dedicated human interaction studies are absent. On mechanism, arecoline would be expected to add to the effects of other cholinergic agents (cholinesterase inhibitors, muscarinic agonists) and to be opposed by anticholinergics such as atropine, which is the standard antidote for muscarinic overstimulation. No CYP-level interaction profile has been characterised for arecoline in humans; the absence of data is not evidence of absence of interactions.

Dosage

There is no therapeutic dose of arecoline for humans, and no safe level of areca-nut chewing. The figures that exist are historical, experimental or veterinary:

Setting	Form & route	Dose
Alzheimer’s memory studies (1991, 1993)	Purified arecoline, continuous intravenous infusion	0.5–40 mg/day, individually titrated to an inverted-U optimum ^{4,5Reference 4Soncrant TT et al. · 1993RCTMemory improvement without toxicity during chronic, low dose intravenous arecoline in Alzheimer’s disease — randomised placebo-controlled trialView study →Reference 5Raffaele KC et al. · 1991Clinical trialEffects of long-term continuous infusion of the muscarinic cholinergic agonist arecoline on verbal memory in dementia of the Alzheimer type — clinical trialView study →}
Pharmacokinetic study in patients	Purified arecoline, IV over 30 minutes	5 mg ^{3Reference 3International Agency for Research on Can · 2021ReviewArecoline, in: Acrolein, Crotonaldehyde, and Arecoline — IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Volume 128. https://www.ncbi.nlm.nih.gov/books/NBK589584/View study →}
Veterinary taeniacide (dogs)	Arecoline hydrobromide, oral	40 mg daily for 5 days ^{3Reference 3International Agency for Research on Can · 2021ReviewArecoline, in: Acrolein, Crotonaldehyde, and Arecoline — IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Volume 128. https://www.ncbi.nlm.nih.gov/books/NBK589584/View study →}
Veterinary pharmacokinetics (dogs)	Arecoline hydrobromide, oral	3 mg/kg → C_max 60.6 ng/mL at 2 h ^{3Reference 3International Agency for Research on Can · 2021ReviewArecoline, in: Acrolein, Crotonaldehyde, and Arecoline — IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Volume 128. https://www.ncbi.nlm.nih.gov/books/NBK589584/View study →}
Human chewing exposure (not a dose)	Whole areca nut / quid	0.64–2.22 mg per gram of product chewed ^{21Reference 21Jain V et al. · 2017Analysis of alkaloids in areca nut-containing products by liquid chromatography-tandem mass spectrometryView study →}

The two human research figures are intravenous, which is the point: the molecule’s plasma half-life is measured in minutes ^{3Reference 3International Agency for Research on Can · 2021ReviewArecoline, in: Acrolein, Crotonaldehyde, and Arecoline — IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Volume 128. https://www.ncbi.nlm.nih.gov/books/NBK589584/View study →}, so the cognitive result depended on continuous infusion of the isolate under monitoring. Nothing chewed, decocted or swallowed reproduces it. These are research and veterinary figures and are not a personal recommendation.

References

Liu YJ, Peng W, Hu MB, et al. (2016). The pharmacology, toxicology and potential applications of arecoline: a review — review. Pharmaceutical Biology. https://pubmed.ncbi.nlm.nih.gov/27046150/
Volgin AD, Bashirzade A, Amstislavskaya TG, et al. (2019). DARK Classics in Chemical Neuroscience: Arecoline — review. ACS Chemical Neuroscience. https://pubmed.ncbi.nlm.nih.gov/30664352/
International Agency for Research on Cancer (2021). Arecoline, in: Acrolein, Crotonaldehyde, and Arecoline — IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Volume 128. https://www.ncbi.nlm.nih.gov/books/NBK589584/
Soncrant TT, Raffaele KC, Asthana S, et al. (1993). Memory improvement without toxicity during chronic, low dose intravenous arecoline in Alzheimer’s disease — randomised placebo-controlled trial. Psychopharmacology (Berl). https://pubmed.ncbi.nlm.nih.gov/7871052/
Raffaele KC, Berardi A, Asthana S, et al. (1991). Effects of long-term continuous infusion of the muscarinic cholinergic agonist arecoline on verbal memory in dementia of the Alzheimer type — clinical trial. Psychopharmacology Bulletin. https://pubmed.ncbi.nlm.nih.gov/1775605/
Lan Q, Guan P, Huang C, et al. (2022). Arecoline induces an excitatory response in ventral tegmental area dopaminergic neurons in anesthetized rats — animal model. Frontiers in Pharmacology. https://pubmed.ncbi.nlm.nih.gov/35548350/
Yen HY, Chen PH, Ko YC, et al. (2018). Betel quid chewing, personality and mood: betel quid chewing associated with low extraversion and negative mood — cross-sectional survey. Substance Use & Misuse. https://pubmed.ncbi.nlm.nih.gov/29419352/
Warnakulasuriya S, Chen THH (2022). Areca nut and oral cancer: evidence from studies conducted in humans — systematic review. Journal of Dental Research. https://doi.org/10.1177/00220345221092751
Zhang P, Chua NQE, Dang S, et al. (2022). Molecular mechanisms of malignant transformation of oral submucous fibrosis by different betel quid constituents — does fibroblast senescence play a role? — review. International Journal of Molecular Sciences. https://pubmed.ncbi.nlm.nih.gov/35163557/
Oliveira NG, Ramos DL, Dinis-Oliveira RJ (2021). Genetic toxicology and toxicokinetics of arecoline and related areca nut compounds: an updated review. Archives of Toxicology. https://doi.org/10.1007/s00204-020-02926-9
Mishra G, Ranganathan K (2010). Matrix metalloproteinase-1 expression in oral submucous fibrosis: an immunohistochemical study — case-control tissue study. Indian Journal of Dental Research. https://pubmed.ncbi.nlm.nih.gov/20930336/
Kuo TM, Luo SY, Chiang SL, et al. (2015). Fibrotic effects of arecoline N-oxide in oral potentially malignant disorders — in vitro and animal model. Journal of Agricultural and Food Chemistry. https://pubmed.ncbi.nlm.nih.gov/26061808/
Javed F, Al-Hezaimi K, Warnakulasuriya S (2012). Areca-nut chewing habit is a significant risk factor for metabolic syndrome: a systematic review. The Journal of Nutrition, Health & Aging. https://doi.org/10.1007/s12603-011-0353-5
Shafique K, Zafar M, Ahmed Z, et al. (2013). Areca nut chewing and metabolic syndrome: evidence of a harmful relationship — cross-sectional study. Nutrition Journal. https://doi.org/10.1186/1475-2891-12-67
Javed F, Bello Correra FO, Chotai M, et al. (2010). Systemic conditions associated with areca nut usage: a literature review — review. Scandinavian Journal of Public Health. https://pubmed.ncbi.nlm.nih.gov/20688790/
Siregar P, Audira G, Castillo AL, et al. (2022). Comparison of the psychoactive activity of four primary areca nut alkaloids in zebrafish by behavioral approach and molecular docking — animal model. Biomedicine & Pharmacotherapy. https://pubmed.ncbi.nlm.nih.gov/36271580/
Zhang X, Cui J, Sun J, et al. (2025). Neuroprotective effects and mechanisms of arecoline against H2O2-induced damage in SH-SY5Y cells — in vitro. International Journal of Molecular Sciences. https://pubmed.ncbi.nlm.nih.gov/41226395/
Chen QY, Zhang Y, Ma Y, et al. (2024). Inhibition of cortical synaptic transmission, behavioral nociceptive, and anxiodepressive-like responses by arecoline in adult mice. Molecular Brain. https://pubmed.ncbi.nlm.nih.gov/38886822/
Di W, Xie S, Shen J, et al. (2025). Arecoline triggers psychostimulant responses by modulating the intestinal microbiota to influence neurotransmitter levels and digestive enzyme activity — animal model. Pharmaceuticals. https://doi.org/10.3390/ph18060794
Shrestha J, Shanbhag T, Shenoy S, et al. (2010). Antiovulatory and abortifacient effects of Areca catechu (betel nut) in female rats. Indian Journal of Pharmacology. https://pubmed.ncbi.nlm.nih.gov/21206624/
Jain V, Garg A, Parascandola M, et al. (2017). Analysis of alkaloids in areca nut-containing products by liquid chromatography-tandem mass spectrometry. Journal of Agricultural and Food Chemistry. https://pubmed.ncbi.nlm.nih.gov/28190359/
Dakkak A, El Berbri I, Petavy AF, et al. (2017). Echinococcus granulosus infection in dogs in Sidi Kacem Province (North-West Morocco) — cross-sectional survey. Acta Tropica. https://pubmed.ncbi.nlm.nih.gov/27436811/
Huang G, Zeng D, Liang T, et al. (2024). Recent advance on biological activity and toxicity of arecoline in edible areca (betel) nut: a review — review. Foods. https://pubmed.ncbi.nlm.nih.gov/39682896/